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BLM, the protein product of the gene mutated in
Bloom syndrome, is one of five human RecQ heli-
cases. It functions to separate double Holliday junc-
tion DNA without genetic exchange as a component
of the ‘‘dissolvasome,’’ which also includes topoiso-
merase IIIa and the RMI (RecQ-mediated genome
instability) subcomplex (RMI1 and RMI2). We
describe the crystal structure of the RMI core com-
plex, comprising RMI2 and the C-terminal OB
domain of RMI1. The overall RMI core structure
strongly resembles two-thirds of the trimerization
core of the eukaryotic single-stranded DNA-binding
protein, Replication Protein A. Immunoprecipitation
experiments with RMI2 variants confirm key interac-
tions that stabilize the RMI core interface. Disruption
of this interface leads to a dramatic increase in
cellular sister chromatid exchange events similar to
that seen in BLM-deficient cells. The RMI core inter-
face is therefore crucial for BLM dissolvasome
assembly and may have additional cellular roles as
a docking hub for other proteins.
INTRODUCTION
Bloom syndrome (BS) is a rare autosomal recessive genetic
disorder characterized by proportional dwarfism, sun sensitivity,
an increased susceptibility to infections and diabetes, and a high
occurrence ofmost types of cancer (Bachrati andHickson, 2003;
German, 1993). BS patients are often first diagnosedwith cancer
in their mid-twenties, which is the typical cause of death.
Cells derived from persons with BS show a remarkable increase
in chromosomal rearrangements, gaps, and breaks. The
hallmark feature of BS cells, which is used in diagnosis, is
a tenfold elevated frequency of sister chromatid exchanges
(SCEs). The gene mutated in BS, BLM, encodes one of five
human RecQ DNA helicases. Two other RecQ-linked genetic
diseases are caused by defects in WRN and RecQ4, causing
Werner’s syndrome and Rothmund-Thomson syndrome,
respectively. All three of these genetic disorders are character-
ized by increased genomic instability and cancer predisposition,Structure 18, 1149–11highlighting the importance of RecQ proteins in genome mainte-
nance (Bachrati and Hickson, 2003).
RecQDNA helicases are ubiquitously conserved enzymes that
catalyze the ATP-dependent unwinding of DNAwith a preference
for DNA structures resembling replication and recombination
intermediates such as replication forks, Holliday junctions,
D-loops, and G-quadruplexes (Ouyang et al., 2008). For the
BLM protein, these activities drive multiple cellular activities.
BLM is important in homologous recombination (HR)-dependent
DNA repair, with roles in branch migration (Bachrati et al., 2006;
Karow et al., 2000; van Brabant et al., 2000), RAD51 filament
disruption (Bugreev et al., 2007), and in restarting stalled DNA
replication processes (Ralf et al., 2006). For several of these
reactions, BLM is thought to function as a component of a larger
protein complex termed the ‘‘dissolvasome,’’ in which it partners
with topoisomerase IIIa (Top3a) and the RMI (RecQ-mediated
genome instability) subcomplex, comprising RMI1 and RMI2
(Raynard et al., 2006; Singh et al., 2008; Wu et al., 2006;
Xu et al., 2008; Yin et al., 2005).
The dissolvasome specifically acts on double Holliday junction
intermediates in HR, creating noncrossover products in a process
termed ‘‘dissolution’’ (Wuetal., 2006;WuandHickson, 2003). This
is of particular interest both for the normal function of the dissolva-
some in HR and for BS pathology: since only noncrossover prod-
uctsare formed,adefect in thisprocesscouldexplain the increase
in SCEs in Bloom syndrome. Dissolution activity is proposed to
occur through branch migration by BLM, which creates a hemi-
catenated structure that can then be resolved by Top3a (Wu
and Hickson, 2003). RMI1 stimulates this process (Wu et al.,
2006) and themore recentlydiscoveredRMI2 is thought toprovide
stability to the complex (Singh et al., 2008; Xu et al., 2008).
Sequence analysis of RMI1 and RMI2 indicates that the
proteins have three oligonucleotide/oligosaccharide-binding
(OB) folds: two in RMI1 (OB1 and OB2) and one in RMI2 (OB3)
(Figure 1A). RMI1 OB1 interacts with BLM and Top3a, whereas
OB2 interacts with OB3 from RMI2 (Xu et al., 2008). Interestingly,
the OB2 and OB3 domains both share sequence homology with
domains found within Replication Protein A (RPA), the heterotri-
meric eukaryotic single-stranded (ss) DNA-binding protein (Xu
et al., 2008). RPA contains six OB folds, which are also known as
DNA-binding domains (DBDs) because of their importance in
ssDNA binding. A subset of these domains in RPA is responsible
for the assembly of RPA heterotrimers, with one OB domain from
each RPA subunit (RPA70 DBD-C, RPA32 DBD-D, and RPA14)
contributing to a core trimerization structure. RPA trimerization58, September 8, 2010 ª2010 Elsevier Ltd All rights reserved 1149
Figure 1. Structural Features of the RMI Core Complex
(A) Schematic diagram of the domain structures of human RMI1 and RMI2. Interacting OB domains comprising the RMI core complex are shown in green (RMI1
OB2) and blue (RMI2 OB3). Additional RMI1 domains (domain of unknown function, DUF, and an OB domain that interacts with Top3a and BLM [OB1]) are indi-
cated.
(B) Ribbon diagram of the crystal structure of the RMI core complex. RMI1 OB2 (green, residues 475–625), and RMI2 (blue, residues 17–147) are rendered using
PyMol (Delano, 2002).
(C) Ribbon diagram of the crystal structure of the RPA trimerization core (Bochkareva et al., 2002) shown with RPA70 in the same orientation as RMI1 OB2 in (B).
RPA70 DBD-C (pale green), RPA32 DBD-D (pale blue), and RPA14 (pink) are shown.
(D) Superposition of RMI1 OB2 with RPA70 DBD-C. The color scheme and orientation are presented as in (B) and (C).
(E) Superposition of RMI2 with RPA32 DBD-D (Deng et al., 2007). DNA-stacking side chains are shown for RPA32 DBD-D. There are no analogous aromatic resi-
dues in RMI2.
See also Figure S1.
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from the OB domains (Bochkarev and Bochkareva, 2004;
Bochkareva et al., 2002). RMI OB2 and OB3 domains share
significant sequence similarity with two of the three trimerization
domains from RPA (RPA70 DBD-C and RPA32 DBD-D, respec-
tively), but whether the RMI complex interfacewas similar to RPA
was not known.
Here, we describe the high-resolution X-ray crystal structure
of the human RMI core complex, composed of RMI1 OB2 and
RMI2. Similarly to the arrangement observed in RPA, the RMI
core complex associates via OB folds that are flanked by
C-terminal a helices that form a helical bundle. This overall struc-1150 Structure 18, 1149–1158, September 8, 2010 ª2010 Elsevier Ltture resembles two-thirds of the RPA trimerization core (RPA70
DBD-C/RPA32 DBD-D), but the specific interactions at the
interface are very different. The RPA interface mostly consists
of hydrophobic interactions between C-terminal helices,
whereas the RMI interface is much larger and includes electro-
static interactions as well as an extensive hydrophobic interface.
We have identified residues critical to the RMI interface and
show that disruption of the RMI subcomplex leads to an overall
increase in SCEs in vivo. These findings point to a primary role for
the RMI core complex in stabilizing the BLM dissolvasome and
also hint at possible functions for the core as a hub for docking
additional cellular factors.d All rights reserved
Table 1. X-Ray Data Collection and Structure Determination
Statistics
Native SeMet
Data Collection
Wavelength, A˚ 0.97856 0.97933
Resolution range
(high resolution bin), A˚
30–1.55
(1.58–1.55)
50–2.14
(2.18–2.14)
Space group P212121 P212121
Unit Cell (a, b, c [A˚]) 42.10, 42.22,
152.24
41.92, 42.03,
152.87
(a, b, g []) 90, 90, 90 90, 90, 90
Completeness, % 97.0 (83.0) 99.9 (99.6)
Total/unique reflections 423,921/39,281 213,642/15,791
Redundancy 10.8 (5.3) 13.5 (12.6)
<I/sI > 25.7 (2.4) 21.5 (20.2)
Rsym,
a % 11.5 (37.8) 10.0 (20.8)
Phasing
Figure of merit 0.756
Refinement
Resolution, A˚ 30–1.55
Rwork/Rfree,
b % 19.5/23.1
Rms deviations
Bonds, A˚ 0.008
Angles,  1.20
Ramachandran
statistics, %
Most favored 93.8
Allowed 5.8
Generously allowed 0.4
Disallowed 0.0
Number of atoms
Protein 2269
Solvent 259
<B factor >, A˚2
Protein 17.4
Solvent 28.9
aRsym = SSjjIj - < I > jSIj, where Ij is the intensity measurement for reflec-
tion j and <I > is the mean intensity for multiply recorded reflections.
bRwork/Rfree = SkFobsj - jFcalck/jFobsj, where the working and free R
factors are calculated by using the working and free reflection sets,
respectively. The free R reflections (5% of the total) were held aside
throughout refinement.
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Defining the RMI Core Complex
We initially set out to investigate the structure of full-length
human RMI1 in complex with RMI2 (the RMI subcomplex).
However, isolated RMI1 and RMI1 in complex with RMI2 were
prone to proteolytic degradation, making either a poor crystallo-
graphic target. Limited proteolysis was used to define a stable
complex that would be more appropriate for crystallographic
trials. The RMI subcomplex was purified and subjected to limited
proteolytic treatment with subtilisin, trypsin, or a-chymotrypsin
and then analyzed by SDS-PAGE. The stability of RMI2 was
remarkable, as it was almost completely resistant to all three
proteases, while RMI1 was rapidly degraded by each of the
proteases. Trypsin treatment produced a fragment migrating
near the 16.5-kDa marker, which appeared after 5 min and
was stable throughout the experiment (see Figure S1 available
online). Mass spectrometric analysis determined that this frag-
ment included the C terminus of RMI1 (residues 473–625), which
comprises the C-terminal RMI1 OB fold (OB2) (Figure 1A). This
protease-resistant complex consisting of RMI1 OB2 and RMI2
defined a minimal RMI core complex. The RMI core complex
was coexpressed and purified for subsequent structural and
biochemical experiments. The complex eluted with 1:1 stoichi-
ometry in size-exclusion chromatographic analysis (Figure S1)
and trypsin proteolysis yielded no degradation, consistent with
formation of a stable minimal heterodimeric RMI core.
Crystal Structure of the RMI Core Complex
The RMI core complex was crystallized and its structure was
determined to 1.55 A˚ resolution using single wavelength anoma-
lous dispersion to phase a selenomethionine-substituted variant
of the complex (Table 1). The refined structure contains residues
475–625 of RMI1 and residues 17–147 of RMI2. Electron density
defining the N terminus of RMI2 was missing, which could indi-
cate that this region of the domain is structurally dynamic.
The same N-terminal segment is not well conserved among
RMI2 homologs (Xu et al., 2008). The RMI core complex struc-
ture was refined with good bond geometry and crystallographic
statistics (Table 1).
Within the RMI core complex, both the RMI1 OB2 domain and
RMI2 fold to form OB domains that are flanked by additional
helical elements (Figure 1B). The canonical OB fold is defined
by a five-stranded b-barrel structure that is often supported by
an a helix present in the region between the third and fourth
strands (Murzin, 1993). The RMI1 OB2 domain has each of these
elements along with two additional helices between strands 3
and 4 and a C-terminal helix. These helices are structurally
similar to elements that are present in RPA, as is described
below. RMI2 lacks the canonical OB-fold helix but clearly forms
the core b-barrel OB-fold structure with an N-terminal helix that
packs against the b-barrel RMI2 core. As is the case with the
RMI1 OB2 domain, RMI2 also has an additional C-terminal helix
that is similar to a helix found in RPA.
Comparison of the RMI Core Complex and the RPA
Trimerization Core
Structural comparison of the RMI core complex to other
OB-domain proteins revealed a striking similarity with the coreStructure 18, 1149–11trimerization domain of RPA, the major eukaryotic ssDNA-
binding protein. The RPA trimerization core interface is formed
among OB folds present in RPA70, RPA32, and RPA14, with
C-terminal a helices that flank the core OB folds. These helices
form a parallel trihelical bundle that provides a large portion of
the interface (Bochkareva et al., 2002) (Figure 1C). In a similar
fashion, the interface between RMI1 and RMI2 is stabilized by
contacts between the two C-terminal a helices, which align in
parallel. A least-squares alignment (Holm et al., 2008) of RPA70
DBD-C with the RMI1 OB2 domain correspondingly aligns RMI2
with RPA32 DBD-D, with the two C-terminal helices aligning58, September 8, 2010 ª2010 Elsevier Ltd All rights reserved 1151
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Structure and Function of the RMI Core Complexanalogously (Figure 1D). The RPA70 DBD-C and RMI1 OB2
domains align with a root mean square deviation (rmsd) of
3.2 A˚ for 122 common Ca atoms, which includes structurally
similar helical motifs positioned in the loop between b strands
3 and 4 (L34 loop) of both proteins. The RMI1 and RPA70 L34
loops are distinct, however, as the helices in RMI1 L34 extend
further from the core OB domain than those from RPA70. A
second major difference between these two domains is that
the loop connecting b strands 2 and 3 (L23 loop) in RPA70
DBD-C contains a zinc ribbon motif whereas the corresponding
loop in RMI1 lacks this motif. This RPA70 zinc-binding region is
thought to contribute to DNA binding in RPA (Bochkareva et al.,
2002; Lao et al., 1999; Pestryakov et al., 2003).
Least-squares alignment of RMI2with RPA32DBD-D, which is
the most similar protein to RMI2 in the Protein Data Bank, show
that the two proteins align with a rmsd of 2.2 A˚ for 112 common
Ca atoms (Figure 1E). Interestingly, RMI2 also shares significant
structural similarity with Schizosaccharomyces pombe Stn1N
(2.5 A˚ for 115 common Ca atoms) and Ten1 (2.3 A˚ for 102
common Ca atoms) which, along with Cdc13, form a heterotri-
meric RPA-like complex called CST involved in telomere mainte-
nance (Gao et al., 2007; Sun et al., 2009). The CST complex is
conserved in humans as Stn1, Ten1, and Ctc1 and is thought
to assemble through an RPA-like clustering of OB domains
(Miyake et al., 2009; Surovtseva et al., 2009).
There are two key functional differences between the RMI and
RPA complexes that appear to be reflected in their respective
core structures. The first is that RPA binds DNA whereas
previous studies indicate that RMI does not (Xu et al., 2008).
Accordingly, the aromatic residues used for DNA binding in
RPA are not conserved in the structure of the RMI core complex
(Figure 1E). The second major difference is that the RMI core
complex exists as a heterodimer, but the RPA core is a hetero-
trimer (Figures 1B and 1C). Whether a third protein also docks
against the RMI core complex to complete a heterotrimer is
not yet known.
The RMI Core Complex Interface Is Distinct from RPA
The RMI interface is large, burying 33 residues of RMI1 OB2 and
36 residues of RMI2, which together corresponds to a buried
surface area of 2610 A˚2 (computed using PISA; Krissinel and
Henrick, 2007). Surface electrostatic representation of the
structure reveals the complexity of the interface, as hydro-
phobic, basic, and acidic surfaces on RMI1 and RMI2 are all
involved in complex formation (Figure 2). Lys121 of RMI2 has
been previously posited to play a role at the interface (Singh
et al., 2008; Xu et al., 2008), and indeed it forms apparent
interactions with carbonyl groups from Ile514 and Ile586 of
RMI1 in the core complex structure (Figure 2B). A second impor-
tant ionic interaction is formed between the side chains of RMI2
Asp141 and RMI1 Arg622 (Figure S2), both of which are in the
C-terminal helices of the proteins. Other contributing residues
from this helix in RMI2 are Glu140, which interacts with RMI1
Lys625, and residues His131 and Glu138, which interact with
Lys511 of RMI1. Additionally, Asn128, which is adjacent to the
RMI2 C-terminal a helix interacts with the carbonyl oxygen of
Val611 of RMI1. There are two other potentially important inter-
facing residues away from the C terminus: the carbonyl oxygen
of RMI2 Ser20 interacts with the Tyr540 side chain of RMI1,1152 Structure 18, 1149–1158, September 8, 2010 ª2010 Elsevier Ltand the main chain amide of RMI2 Arg93 interacts with the
RMI1 Asp587 side chain. Finally, two highly conserved RMI2
residues that have been previously mutated and shown to
disrupt complex formation (Lys24 and Trp59) were located in
the center of the RMI core complex interface (Figure 2C) (Singh
et al., 2008). Trp59 forms a hydrophobic network in the interface,
stacking between Phe513 from RMI1 and the hydrophobic
portion of the Lys24 side chain from RMI2 at the center of the
interface. Notably, the residues that comprise the RMI core
complex interface are evolutionarily well conserved (Figures 2C
and 2D), indicating that the overall arrangement of subunits
with the core observed in the structure is likely to be representa-
tive of most RMI complexes.
Although the overall arrangement of RMI and RPA OB
domains is similar, the size and chemical composition of the
interfaces are distinct. In contrast to the large RMI interface
(2610 A˚2), the corresponding RPA interface (between RPA70
DBD-C and RPA 32 DBD-D) is much smaller (900 A˚2), with fewer
amino acids from each OB fold contributing to the interaction.
In addition, the RMI interface is composed of many electrostatic
and hydrophobic interactions, whereas the RPA interface is
dominated by hydrophobic contacts (Bochkareva et al., 2002).
Furthermore, the residues that make up the RPA trimerization
core are primarily from the C-terminal a helices that extend
from the RPA OB domains, whereas those composing the RMI
core complex are from both the OB domains and the C-terminal
helices.
Coimmunoprecipitation Experiments Demonstrate
the Importance of RMI Core Complex Interface
Coimmunoprecipitation experiments were used to test the
importance of the identified interface of the RMI core complex
in assembly of the BLM dissolvasome. Based on the structural
insights described above, expression constructs were produced
that encode FLAG-epitope labeled single-site variants of RMI2
that are predicted to destabilize the complex. These RMI2 vari-
ants were then transiently transfected into HeLa cells and the
integrity of the dissolvasome was measured by immunoprecipi-
tating the RMI2 variants and probing for the presence of other
dissolvasome members (BLM, Top3a, and RMI1) by western
analysis.
Initial experiments tested RMI2 variants in which Lys121,
His131, Glu138, or Asp141 were individually changed to alanine.
In agreement with earlier studies, BLM, Top3a, and RMI1 coim-
munoprecipitate with wild-type FLAG-RMI2 (Xu et al., 2008)
(Figure 3A). Interestingly, when the RMI2 alanine variants were
used in the assay, only the Asp141Ala variant showed a major
defect in coimmunoprecipitation with BLM, Top3a, and RMI1.
Given the large interface in the RMI core complex structure,
we reasoned that alanine-substitution variants may not be suffi-
cient to disrupt the interface in all cases. To test this idea, charge
reversal RMI2 variants Lys121Glu, Asp141Lys, and a variant that
included both changes were tested in the coimmunoprecipita-
tion assay. With these more dramatic changes, coimmunopreci-
pitation was either greatly diminished (Lys121Glu RMI2 variant)
or entirely eliminated (Asp141Lys and double-reversal variants)
(Figure 3A). These results thus support a structural model in
which Lys121 and Asp141 are key residues at the interface
between RMI1 and RMI2.d All rights reserved
Figure 2. RMI Core Complex Interface
(A) Top: structure of the RMI core complex showing semitransparent surface and ribbon representations in the same orientation and color scheme as in 1B.
Bottom: split view of the RMI core complex in which both proteins are separated and rotated 90 to show interacting surfaces. The interface between RMI1
and RMI2 is shown with connected lines indicating residues forming hydrogen bonds or ionic interactions. The interface is depicted using surface electrostatics,
showing electropositive (blue) and electronegative (red) surface potential.
(B) 2FoFc electron density map (1.5 s) showing interaction of RMI1 Ile514 and Ile586 with RMI2 Lys121.
(C) The interface between RMI1 and RMI2 is shown in the same orientation as 2A, bottom. RMI1 and RMI2 are colored to indicate residues that are invariant (red),
highly conserved (orange), or poorly conserved (green for RMI1 and blue for RMI2) among identified RMI1 and RMI2 proteins from human, bovine, mouse, zebra-
fish, and Arabidopsis sequences. Three of the invariant residues that form a hydrophobic interaction network are labeled: RMI1 Phe513, RMI2 Lys24, and RMI2
Trp59.
(D) The sequence for the RMI core complex is shown, with secondary structural features labeled above as boxes (a helices) and arrows (b strands). Red and
orange lettering indicates invariant and highly conserved residues, respectively.
See also Figure S2.
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Figure 3. Coimmunoprecipitations of the dissolvasome complex
components with RMI2 variants.
(A) Western analysis of dissolvasome complex components (BLM, Top3a,
RMI1, and FLAG-RMI2) from immunoprecipitates of FLAG-tagged RMI2 tran-
siently expressed in HeLa cells.
(B) Western analysis of dissolvasome complex components (Top3a and
FLAG-RMI2) from immunoprecipitates of FLAG-tagged RMI2 stably
expressed in chicken DT40 cells. RMI1 and BLM were not detected in DT40
cells because the antibodies raised against human proteins fail to recognize
the chicken homologs.
See also Figure S3.
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Structure and Function of the RMI Core ComplexDisrupting the RMI Core Complex Interface Increases
SCE Formation In Vivo
The consequences of destabilizing the RMI core complex
interface on dissolvasome function in vivo were tested next.
Disruption of the RMI2 gene in chicken DT40 cells leads to
a 5-fold increase in SCE formation that can be suppressed
by expressing human RMI2 protein in the mutant cells
(Xu et al., 2008). As was observed in HeLa cells, experiments
in DT40 cells verified that immunoprecipitation of the human
RMI2 protein coprecipitated a member of the dissolvasome
(Top3a) whereas RMI core complex-destabilizing RMI2 variants
failed to do so (Figure 3B). These controls allow the use of the
DT40 system to analyze the chromosomal effects of the RMI2
interface variants.
Assays were next performed to test the effects of RMI2
variants on SCE levels in vivo. As was observed previously (Xu
et al., 2008), the mean number of SCE per cell increased 6-
fold in the rmi2/ cells compared with that of the wild-type
DT40 cells, but this difference was suppressed by expression
of the FLAG-tagged human RMI2 protein (Figure 4). Consistent
with retention of the RMI subcomplex, the His131Ala RMI2
variant showed no significant increase in the mean number of
SCEs/cell when compared with wild-type RMI2. Similarly, the
Glu138Ala RMI2 variant, which also retained complex integrity,
showed only a slight increase in mean SCEs/cell (less than
2-fold). In contrast, drastic changes in the mean number of1154 Structure 18, 1149–1158, September 8, 2010 ª2010 Elsevier LtSCEs/cell were observedwith the Lys121 and Asp141RMI2 vari-
ants. The Asp141Ala and Asp141Lys variants had 2.8- and 8.6-
fold increases, respectively. The Lys121Ala, Lys121Glu, and
Lys121Glu/Asp141Lys mutations all had 5- to 6-fold increases
in mean SCEs/cell relative to wild-type RMI2-complemented
experiments. These values are very similar to the SCE levels of
rmi2/ cells. With one exception (Lys121Ala), these data
parallel the coimmunoprecipitation results; RMI2 variants that
failed to assemble with the dissolvasome led to increases in
cellular SCE events. Folding defects or aberrant RMI core
complex formation by the Lys121Ala RMI2 variant were ruled
out as possible explanations for its unusual behavior. The
circular dichroic spectrum of the isolated Lys121Ala RMI2
variant showed that the protein was folded, and an X-ray crystal
structure of the variant in complex with the RMI1 OB2 domain
was nearly indistinguishable from that of the wild-type RMI
core complex except for the Lys-to-Ala alteration (Figure S3).
While the possibility still exists that there may be differences in
thermodynamic stability between the two proteins, the effects
of the Lys121Ala RMI2 variant appear to indicate a role for the
Lys121 residue beyond RMI complex stabilization.
DISCUSSION
RMI1 and RMI2 define a subcomplex that is an integral
component of the BLM dissolvasome (Singh et al., 2008; Xu
et al., 2008; Yin et al., 2005). The RMI subcomplex is stabilized
by binding of the C-terminal OB fold of RMI1 (OB2) to RMI2,
which itself comprises an OB fold (OB3) (Figure 1A) (Singh
et al., 2008; Xu et al., 2008). Here, we report the 1.55 A˚ resolution
X-ray crystal structure of the RMI core complex, revealing a large
interface that mediates RMI1/RMI2 heterodimer formation. This
interface has been verified using coimmunoprecipitation exper-
iments in HeLa and DT40 cells. Furthermore, disruption of the
RMI interface was shown to be linked to a profound increase
of SCEs in DT40 cells. Our data support a model in which the
RMI core complex interface is critical for stabilizing the BLM
dissolvasome, because RMI2 destabilizing mutations at the
RMI interface lead to increased SCE levels similar to those
observed in cells lacking RMI2 altogether. Additional possible
roles for the RMI core complex domains in higher order protein
complex assembly are also supported as described below.
Comparison of the RMI Core Complex and the RPA
Trimerization Core
It has been suggested previously that the RMI OB domains
would resemble those from RPA (Xu et al., 2008). Consistent
with this hypothesis, the overall structures of the RMI OB
domains are strikingly similar to those of the RPA OB domains,
and the two complexes assemble using analogous surfaces
(Figure 1). Interestingly, in spite of this overall similarity, the
RMI core complex and the RPA trimerization core interfaces
also display significant differences. First, while the RPA interface
is primarily hydrophobic in nature, the RMI interface consists of
a network of hydrogen bonds and salt bridges in addition to
hydrophobic interactions. Second, while nearly all of the interac-
tions within the RPA interface are mediated by residues in the
a helices C-terminal to the OB domains, significant contacts
between the RMI core subunits are contributed both by the OBd All rights reserved
Figure 4. SCE Frequencies Observed with
Different RMI2 Variants
The number of SCEs per cell in chicken DT40 cells
are shown as a histogram in which each point in
a column is the number of SCE events in a single
cell. The mean level of SCEs/cell is displayed as
a dark black line and numerically at the top of
the column. Statistical significance is indicated
with *** (p < 0.001) and ND (p > 0.05). ‘‘DT40’’
denotes wild-type DT40 cells, ‘‘rmi2/’’ denotes
DT40 cells lacking RMI2, ‘‘wild-type’’ denotes
rmi2/ cells complemented with human RMI2,
and the remainder denotes the human RMI2 vari-
ants that have been substituted.
See also Figure S3.
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extends the buried surface area in the RMI core complex relative
to that of RPA. These distinctions could contribute to the partic-
ular functions of the two complexes.
One important functional difference between RPA and RMI is
that the RMI subcomplex lacks DNA-binding activity. Previous
work has shown that isolated human and yeast RMI1 bind
DNA weakly in vitro (Chen and Brill, 2007; Mullen et al., 2005;
Raynard et al., 2008; Wu et al., 2006), but that the RMI subcom-
plex is unable to bind DNA (Xu et al., 2008). Accordingly, the RMI
core complex lacks analogous DNA-binding residues found in
RPA, as the surface-exposed aromatic residues that might stack
with ssDNA bases are buried in the RMI core complex interface.
Exposure of these interface residues in the isolated RMI1 could
explain its previously observed weak DNA binding (Raynard
et al., 2008).
Perhaps the most noticeable difference between the RMI and
RPA core structures is the lack of a third partner in the RMI sub-
complex. RPA forms a heterotrimeric complex that, in addition to
the RPA70 and RPA32, includes RPA14 (Figure 1C). In contrast,
the RMI core complex lacks a third partner to complete
a possible trimeric structure. Since the RMI subcomplex further
associates with other proteins, it is tantalizing to speculate that
another protein could dock onto the RMI core structure in
a similar manner to that of RPA14 binding RPA70/RPA32.
Possibilities include BLM or Top3a, which comprise the remain-
ing dissolvasome members. However, these proteins have been
shown to associate with an N-terminal OB domain (OB1) frag-
ment of RMI1 and in the absence of RMI2 (Raynard et al.,
2008). A second possibility is that the RMI1 OB1 domain or
some other OB-fold-containing protein might bind to the RMI
core complex; such an interaction could potentially regulate dis-
solvasome complex formation or activation. A final, nonexclusiveStructure 18, 1149–1158, September 8, 2010 ªpossibility is that other proteins could
form complexes with the dissolvasome
by docking onto the ‘‘open’’ site on the
RMI core complex. These could include
FANCM, for example, which has recently
been shown to be able to bind to the
RMI1 OB2 domain (Deans and West,
2009). Future experiments will be re-
quired to determinewhether the heterodi-
meric RMI core complex described hereis able to associate with an additional protein partner (or
partners) in an RPA-like assembly.
Importance of RMI Subcomplex Interface
in Suppressing SCE Levels
Based on the RMI core complex structure, RMI2 variants that
have lost the ability to assemble with RMI1 and the rest of the
dissolvasome were shown to lead to an increase in SCE levels
in vivo. RMI2 variants Asp141Ala, Lys121Glu, Asp141Lys, and
Lys121Glu/Asp141Lys either fail to assemble with the dissolva-
some or do so with diminished stability (Figure 3) and lead to
2.8- to 8.6-fold increase in mean SCE events/cell compared
with wild-type RMI2 (Figure 4). In contrast, RMI2 variants
His131Ala and Glu138Ala retain the ability to assemble with
the dissolvasome and have more modest increases in mean
SCE events/cell of 1.2- and 1.8-fold, respectively. These data
thus define a relationship between destabilization of the RMI
subcomplex and an increase in cellular SCE events, and indicate
a role for the RMI proteins in stabilization and/or activation of the
dissolvasome within cells.
The Lys121Ala RMI2 variant presented an intriguing exception
to the parallel between RMI subcomplex destabilization and
elevated SCE levels. This variant retained a normal ability to
assemble into the dissolvasome (Figure 3) but had mean SCE/
cell levels that were nearly the same as the rmi2/ control
(Figure 4). Indeed, even the Lys121Glu charge reversal variant
retained a weakened ability to assemble within the dissolva-
some. Similar observations for RMI2 Lys121Ala variants have
been noted in the past (Singh et al., 2008; Xu et al., 2008).
What could account for this behavior? One possibility is that
the Lys121 RMI2 variants are misfolded or that they form aber-
rant complexes with RMI1 that have an altered interface.
However solution studies and a crystal structure of the2010 Elsevier Ltd All rights reserved 1155
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explanation, at least in vitro (Figure S3). Another possibility is that
the observed difference is caused by a change in the rates of
association or dissociation of the RMI core complex that cannot
be detected by the coimmunoprecipitation assay. It is possible
that the dissolvasome could be regulated by this key interaction
through the dynamics of association instead of a constant equi-
librium state. A final hypothesis is that Lys121 from RMI2 is
important for functions beyond RMI complex stabilization.
Notably, RMI2 Lys121 is positioned on the periphery of the
RMI1/RMI2 interface and its interaction with two carbonyl
groups in RMI1 appears to contort the Lys121 side chain away
from the surrounding solvent (Figure S3). It is possible that in
the context of the full dissolvasome Lys121 assumes an alter-
nate conformation in which its charged group is presented on
the surface of the RMI subcomplex to foster interactions with
other cellular binding partners. Such a possibility could explain
the dispensability of RMI2 Lys121 for dissolvasome formation
but its clear importance in cellular activity. Furthermore, the
Lys121 surface is on the opposite side of the RMI core complex
from the putative RPA-like interaction site, which could indicate
that the complex has two protein interaction sites and could
possibly act as a hub for docking multiple protein partners.
Concluding Remarks
The structure of the RMI core complex and analysis of RMI
protein variants has revealed the importance of RMI subcomplex
integrity in genome stability. It is interesting that not only are RMI
and RPA both complexes that interact via OB folds, but both
complexes also mediate BLM function. RPA physically interacts
with BLM and stimulates its ability to unwind DNA (Brosh et al.,
2000). Furthermore, there are other OB-fold-containing com-
plexes with roles in genome maintenance such as the CST
complex and TPP-POT1, both of which act at telomeres. The
CST complex has been proposed to form an RPA-like complex
specifically at telomeres (Miyake et al., 2009; Surovtseva et al.,
2009), and a recent S. pombe Stn1-Ten1 structure has also iden-
tified a similarity to the RPA interface (Sun et al., 2009). This and
other studies point to a growing number of genomemaintenance
roles for OB-fold-containing proteins that extend beyond the
ssDNA-binding activities for which the domain is named.
EXPERIMENTAL PROCEDURES
Plasmids, Protein Overexpression, and Purification
Purification of the RMI Subcomplex
A plasmid pCDFDuet-1 (Novagen) encoding RMI1 and RMI2 (Xu et al., 2008)
was transformed into Rosetta 2 (DE3) Escherichia coli transformed with pLysS
(Novagen). Cells were grown at 30C in Luria Broth supplemented with
25 mg/ml streptomycin and 50 mg/ml chloramphenicol. At an OD600
of 0.6 cells were induced to overexpress protein with 0.3 mM isopropyl
b-D-thiogalactopyranoside at25C for 3 hr. Cells were harvested with centri-
fugation, frozen at80C, and resuspended at 4C in PBS (10 mM phosphate
[pH 7.4], 138 mM NaCl, and 2.7 mM KCl) with 5% glycerol, 1 mM phenylme-
thanesulfonylfluoride (PMSF), and protease-inhibitor tablets (Roche).
All subsequent purification steps were performed at 4C. Cells were lysed
by sonication and centrifuged for 30 min at 15,000 rpm. Ammonium sulfate
(35% w/v) was added to the soluble lysate and the resulting pellet was resus-
pended in PBS with 5% glycerol and then incubated with Ni-NTA resin
(QIAGEN) for 45 min. The resin was poured into a column and washed twice
with PBS containing 10mM imidazole and 500mMNaCl. The RMI subcomplex1156 Structure 18, 1149–1158, September 8, 2010 ª2010 Elsevier Lteluted in 300 mM imidazole in TBS buffer (50 mM Tris-HCl [pH 7.5], 5% glyc-
erol, 150 mM NaCl). The eluate was diluted 1:5 in Q buffer (25 mM Tris-HCl,
pH 7.5, 5% glycerol) and loaded onto a HiPrep Q FF column (Amersham).
The bound protein was eluted with a linear (0.1 M to 0.5 M) NaCl gradient.
The peak fractions were used for limited proteolysis.
Purification of the RMI Core Complex
Open-reading frames encoding RMI1 OB2 and RMI2 (or an RMI2 variant) were
separately subcloned from the above plasmid into a modified pGEX4T-1
plasmid (Amersham) that expresses an amino-terminal glutathione S-trans-
ferase (GST) tagged RMI1 OB2 and amino-terminal 63-histidine tagged
RMI2. This plasmid was transformed into Rosetta 2 (DE3) E. coli cells trans-
formed with pLysS (Novagen) and grown at 30C in LBmedium supplemented
with 100 mg/ml ampicillin and 50 mg/ml chloramphenicol. At an OD600
of 0.6 cells were induced to overexpress protein with 0.5 mM isopropyl
b-D-thiogalactopyranoside at 30C for 3 hr. Cells were harvested with centri-
fugation, frozen at80C, and resuspended at 4C in lysis buffer (50 mM Tris-
HCl [pH 7.5], 20% sucrose, and 600 mM KCl) supplemented with 1 mM PMSF
and protease-inhibitor tablets (Roche). All subsequent purification steps were
performed at 4C. Cells were lysed by sonication and centrifuged for 30 min at
15,000 rpm. The soluble lysate was incubated with Ni-NTA resin (QIAGEN) for
30 min and then poured into a column and washed twice with wash buffer
(25 mM Tris-HCl [pH 7.5], 500 mM NaCl, 10 mM imidazole, 100 mM dextrose,
and 10% glycerol). The complex was eluted with 300 mM imidazole in TBS
buffer and then incubated with glutathione Sepharose 4B resin (Amersham)
for 40 min. The resin was then poured into a column, washed twice with
GS4B buffer (25 mM Tris-HCl [pH 7.5], 0.5 mM ethylenediaminetetraacetic
acid (EDTA), 1 mM dithiothreitol (DTT), 10% glycerol) with 500 mM KCl, and
eluted with GS4B buffer supplemented with 150 mM KCl and 20 mM reduced
glutathione. The eluate was incubated with thrombin overnight to remove both
affinity tags, leaving Gly-Ser-His peptides on the amino terminus of both
proteins. The eluate was dialyzed against SPFF buffer (20 mM MES [pH 6.0],
50 mM NaCl, 0.5 mM EDTA, 1 mM DTT, 10% glycerol) and then loaded on
aHiPrep SPFF column (Amersham). The bound protein was elutedwith a linear
(0.05–0.50 M) NaCl gradient. Fractions containing the complex were pooled,
concentrated to < ml and then further purified on a Sephacryl S-100 column
in SPFF buffer. Selenomethionine-incorporated protein was expressed as
previously described (Van Duyne et al., 1993) and purified identically to native
protein. Analytical size-exclusion chromatography was performed on with
a Sephacryl S-200 column in SPFF buffer.
Limited Proteolysis Assay
The purified RMI subcomplex was incubated at a 150:1 molar ratio (complex:-
protease) with subtilisin, trypsin, or a-chymotrypsin in 25 mM Tris-HCl (pH 8),
8 mM DTT, 1 mM EDTA, 150 mM NaCl, and 10% glycerol. Proteolysis was
terminated after 1, 5, 15, and 30 min by adding 23 sample buffer (12.5 mM
Tris-HCl [pH 6.8], 20% glycerol, 5% w/v SDS, 10% b-mercaptoethanol, bro-
mophenol blue) and freezing on dry ice. The products were analyzed by
15% SDS-PAGE and mass spectrometry at the UW Biotechnology Center.
Protein Crystallization and Structure Determination
Wild-type RMI core complex or a RMI core complex formed with Lys121Ala
RMI2 was dialyzed against water. Selenomethionine-incorporated RMI core
complex was dialyzed against 10 mM HEPES (pH 7.1), 1 mM DTT. Core
complex samples (5 mg/ml) were mixed with mother liquor (10 mM HEPES
[pH 7.1], 0.05 M NaSCN, 20% ethylene glycol, 2 mM DTT, and 13% polyeth-
ylene glycol 3350) at a 1:1 (vol) ratio, and benzamidine (1%) was added to
the solution. Crystals were formed by hanging drop vapor diffusion. Crystals
were transferred to a cryoprotectant solution (10 mM HEPES [pH 7.1],
0.05 M NaSCN, 30% ethylene glycol, 2 mM DTT, 15% polyethylene glycol
3350, 1% benzamidine) and flash-frozen in liquid nitrogen. The highest quality
crystals were obtained by microseeding with native crystals.
The structure of the selenomethionine-incorporated RMI core complex was
determined by single-wavelength anomalous dispersion (SAD) phasing. Data
were indexed and scaled using HKL2000 (Otwinowski and Minor, 1997). Sele-
nium positions were identified using SHELX within Crank (Ness et al., 2004)
and an initial structure was built using ARP/wARP (Perrakis et al., 1999). The
structure was improved by rounds of manual fitting using Coot (Emsley and
Cowtan, 2004) and refinement against the native data set using REFMAC5d All rights reserved
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Structure and Function of the RMI Core Complex(Winn et al., 2001). The structure of the RMI core complex that includes RMI2
Lys121Ala variant was determined by molecular replacement using Phaser
(McCoy et al., 2007). The two proteins in the RMI core complex were posi-
tioned as individual search models so that any differences in packing would
be revealed. Refinement was limited to positioning the RMI core complex
subunits. Coordinate and structure factor files have been deposited in the
Protein Data Bank (PDB ID 3MXN).
Coimmunoprecipitation and SCE Assays
FLAG-tagged RMI2 variants were transiently expressed in HeLa cells or stably
expressed in chicken DT40 rmi2/ cells. Nuclear extract was prepared as
described previously (Guo et al., 2009) for coimmunoprecipitation. Coimmu-
noprecipitation experiments were performed using the anti-FLAGM2-agarose
(Sigma) as described (Guo et al., 2009). Polyclonal antibodies for western blot-
ting against BLM, Topo 3a, RMI1, or RMI2 were described elsewhere (Meetei
et al., 2003; Wu et al., 2000; Xu et al., 2008; Yin et al., 2005). The different lanes
were normalized by comparison of FLAG-RMI2 levels. The SCE assay was
performed as described previously (Guo et al., 2009).
ACCESSION NUMBERS
Coordinates and structure factor files have been deposited in the RCSB
Protein Data Bank with accession code 3MXN.
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